VUBILA Trademark

Trademark Overview


On Monday, December 26, 2016, a trademark application was filed for VUBILA with the United States Patent and Trademark Office. The USPTO has given the VUBILA trademark a serial number of 87280944. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 6, 2020. This trademark is owned by Novartis AG. The VUBILA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preve...
vubila

General Information


Serial Number87280944
Word MarkVUBILA
Filing DateMonday, December 26, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 6, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2017

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 9, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, January 6, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 6, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, May 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2019EXTENSION 4 GRANTED
Wednesday, May 29, 2019EXTENSION 4 FILED
Wednesday, May 29, 2019TEAS EXTENSION RECEIVED
Tuesday, November 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 24, 2018EXTENSION 3 GRANTED
Saturday, November 24, 2018EXTENSION 3 FILED
Saturday, November 24, 2018TEAS EXTENSION RECEIVED
Thursday, May 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 29, 2018EXTENSION 2 GRANTED
Tuesday, May 29, 2018EXTENSION 2 FILED
Tuesday, May 29, 2018TEAS EXTENSION RECEIVED
Friday, November 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 22, 2017EXTENSION 1 GRANTED
Wednesday, November 22, 2017EXTENSION 1 FILED
Wednesday, November 22, 2017TEAS EXTENSION RECEIVED
Tuesday, May 30, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2017ASSIGNED TO EXAMINER
Monday, January 9, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 29, 2016NEW APPLICATION ENTERED IN TRAM